Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1027 | 983 | 994 | 1362 | 1560 | 2331 |
Fund Return | 2.71% | -1.74% | -0.62% | 10.86% | 9.31% | 8.83% |
Place in category | 725 | 911 | 690 | 12 | 154 | 163 |
% in Category | 70 | 93 | 77 | 3 | 35 | 58 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seligson Co Global Top 25 Brands Fu | 703.2M | 8.56 | 8.67 | 13.08 | ||
Seligson & Co Global Top 25 Brands | 703.2M | 8.56 | 8.66 | 13.04 | ||
Seligson North American B | 470.11M | 14.56 | 14.20 | 14.73 | ||
Seligson & Co North American A | 470.11M | 14.56 | 14.21 | 14.74 | ||
Seligson & Co Europe Index Fund A | 279.5M | 7.96 | 8.51 | 7.01 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Danske Invest MediLife T | 603.11K | 8.06 | 10.80 | 11.54 | ||
Danske Invest MediLife K | 90.32M | 8.06 | 10.79 | 11.54 | ||
Seligson Co Global Top 25 Pharma A | 269.22M | 2.71 | 10.85 | 8.81 | ||
LahiTapiola Hyvinvointi B | 148.91M | 3.40 | 0.70 | 9.00 | ||
LahiTapiola Hyvinvointi A | 148.91M | 3.40 | 0.69 | 9.00 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Merck&Co | US58933Y1055 | 7.84 | 128.38 | -1.29% | |
J&J | US4781601046 | 6.47 | 150.45 | +0.36% | |
Pfizer | US7170811035 | 6.25 | 28.36 | +1.23% | |
Novartis | CH0012005267 | 6.18 | 93.07 | +0.81% | |
Roche Holding Participation | CH0012032048 | 5.63 | 227.60 | +1.11% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Strong Buy |
Technical Indicators | Strong Buy | Sell | Strong Buy |
Summary | Strong Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review